Please login to the form below

Not currently logged in
Email:
Password:

Merck & Co promotes Roger Pomerantz to knowledge management role

Former global head of infectious diseases assumes new role at the US pharma company

 Roger Pomerantz - Merck & CoMerck & Co has promoted its former global head of infectious diseases Roger Pomerantz to a new role.

Pomerantz becomes the US pharma company's head of worldwide licensing and knowledge management with a wide-ranging remit.

He will lead all licensing deals, acquisitions, academic alliances, regional deals, out-licensing and playing a key part in the Merck Research Venture Fund.

Prior to joining Merck in February 2010 Pomerantz served as global head of infectious diseases and president of Peninsula Pharmaceuticals, a subsidiary of Johnson & Johnson (J&J) focused on antibacterial research.

From 2005-2010, he also served as president of Tibotec Pharmaceuticals, another Johnson & Johnson subsidiary that focuses on antiviral and tuberculosis research and development.

Before J&J Pomerantz spent 15 years in academic medicine at Thomas Jefferson University and Medical School in Philadelphia as professor of Medicine, Biochemistry and Molecular Pharmacology, chief of Infectious Diseases and founding director and chair of the Institute for Research in Human Virology and Biodefense.

7th December 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics